Advanced SearchSearch Tips
Sanguinarine Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Generation of ROS and Modulation of Akt/ERK Signaling Pathways
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Life Science
  • Volume 25, Issue 9,  2015, pp.984-992
  • Publisher : Korean Society of Life Science
  • DOI : 10.5352/JLS.2015.25.9.984
 Title & Authors
Sanguinarine Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Generation of ROS and Modulation of Akt/ERK Signaling Pathways
Hwang, Ju Yeong; Cho, Yung Hyun;
  PDF(new window)
Sanguinarine is a benzophenanthridine alkaloid originally isolated from the roots of Sanguinaria canadensis. It has multiple biological activities (e.g., antioxidant and antiproliferative) and immune-enhancing potential. In this study, we explored the proapoptotic properties and modes of action of sanguinarine in human hepatocellular carcinoma HepG2 cells. Our results revealed that sanguinarine inhibited HepG2 cell growth and induced apoptosis in a dose-dependent manner. The induction of apoptosis by sanguinarine was associated with the up-regulation of Fas and Bax, the release of cytochrome c from the mitochondria to the cytosol, and the loss of the mitochondrial membrane potential. In addition, sanguinarine activated caspase-9 and -8, initiator caspases of the intrinsic and death extrinsic pathways, respectively, and caspase-3, accompanied by proteolytic degradation of poly (ADP-ribose) polymerase. Sanguinarine also triggered the generation of reactive oxygen species (ROS). The elimination of ROS by N-acetylcysteine reversed sanguinarine-induced apoptosis. Furthermore, sanguinarine induced the dephosphorylation of Akt and the phosphorylation of mitogen-activated protein kinases, including extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38. The growth inhibition was enhanced by the combined treatment of sanguinarine with a phosphatidylinositol 3`-kinase (PI3K) inhibitor and an ERK inhibitor but not JNK and p38 inhibitors. Overall, our data indicate that the proapoptotic effects of sanguinarine in HepG2 cells depend on ROS production and the activation of both intrinsic and extrinsic signaling pathways, which is mediated by blocking PI3K/Akt and activating the ERK pathway. Thus, our data suggest that sanguinarine may be a natural compound with potential for use as an antitumor agent in liver cancer.
Apoptosis;extracellular signal-regulated kinase (ERK);PI3K/Akt;reactive oxygen species (ROS);sanguinarine;
 Cited by
HepG2 간암세포에서 미토콘드리아 경로를 통한 개똥쑥 추출물의 Apoptosis 유도 효과,김보민;김근태;김은지;임은경;김상용;김영민;

한국식품영양과학회지, 2016. vol.45. 12, pp.1708-1716 crossref(new window)
Extract from Artemisia annua Linn? Induces Apoptosis through the Mitochondrial Signaling Pathway in HepG2 Cells, Journal of the Korean Society of Food Science and Nutrition, 2016, 45, 12, 1708  crossref(new windwow)
Adhami, V. M., Aziz, M. H., Mukhtar, H. and Ahmad, N. 2003. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer Res. 9, 3176-3182.

Ahsan, H., Reagan-Shaw, S., Breur, J. and Ahmad, N. 2007. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett. 249, 198-208. crossref(new window)

Basini, G., Santini, S. E., Bussolati, S. and Grasselli, F. 2007. Sanguinarine inhibits VEGF-induced Akt phosphorylation. Ann. N. Y. Acad. Sci. 1095, 371-376. crossref(new window)

Bassi, R., Heads, R., Marber, M. S. and Clark, J. E. 2008. Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr. Opin. Pharmacol. 8, 141-146. crossref(new window)

Bedner, E., Li, X., Gorczyca, W., Melamed, M. R. and Darzynkiewicz, Z. 1999. Analysis of apoptosis by laser scanning cytometry. Cytometry 35, 181-195. crossref(new window)

Brenner, D. and Mak, T. W. 2009. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 21, 871-877. crossref(new window)

Choi, W. Y., Kim, G. Y., Lee, W. H. and Choi, Y. H. 2008. Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy 54, 279-287. crossref(new window)

Choi, W. Y., Jin, C. Y., Han, M. H., Kim, G. Y., Kim, N. D., Lee, W. H., Kim, S. K. and Choi, Y. H. 2009. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Anticancer Res. 29, 4457-4465.

Choi, Y. H., Choi, W. Y., Hong, S. H., Kim, S. O., Kim, G. Y., Lee, W. H. and Yoo, Y. H. 2009. Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem. Biol. Interact. 179, 185-191. crossref(new window)

Circu, M. L. and Aw, T. Y. 2001. Reactive oxygen species, cellular redox systems, and apoptosis. Free. Radic. Biol. Med. 48, 749-762.

De Stefano, I., Raspaglio, G., Zannoni, G. F., Travaglia, D., Prisco, M. G., Mosca, M., Ferlini, C., Scambia, G. and Gallo, D. 2009. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem. Pharmacol. 78, 1374-1381. crossref(new window)

Degli Esposti, M. and Dive, C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res.Commun. 304, 455-461. crossref(new window)

Dong, X. Z., Zhang, M., Wang, K., Liu, P., Guo, D. H., Zheng, X. L. and Ge, X. Y. 2013. Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells. Biomed. Res. Int. 2013, 517698.

Duriez, P. J. and Shah, G. M. 1997. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell. Biol. 75, 337-349. crossref(new window)

Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougère, M., Henry, E., Galteau, M. M., Dicato, M. and Diederich, M. 2004. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 68, 1101-1111. crossref(new window)

Fulda, S. and Debatin, K. M. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811. crossref(new window)

Gatti, L., Cossa, G., Tinelli, S., Carenini, N., Arrighetti, N., Pennati, M., Cominetti, D., De Cesare, M., Zunino, F.,Zaffaroni, N. and Perego, P. 2014. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligandbased treatment. J. Pharmacol. Exp. Ther. 348, 360-371. crossref(new window)

Godowski, K. C. 1989. Antimicrobial action of sanguinarine. J. Clin. Dent. 1, 96-101.

Gu, S., Yang, X. C., Xiang, X. Y., Wu, Y., Zhang, Y., Yan, X. Y., Xue, Y. N., Sun, L. K. and Shao, G. G. 2015. Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress. Oncol. Rep. 34, 913-919.

Gupta, S. C., Kim, J. H., Prasad, S. and Aggarwal, B. B. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29, 405-434. crossref(new window)

Han, M. H., Kim, S. O., Kim, G. Y., Kwon, T. K., Choi, B. T., Lee, W. H. and Choi, Y. H. 2007. Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt. Anticancer Drugs 18, 913-921.

Han, M. H., Yoo, Y. H. and Choi, Y. H. 2008. Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy 54,157-165. crossref(new window)

Han, M. H., Park, C., Jin, C. Y., Kim, G. Y., Chang, Y. C., Moon, S. K., Kim, W. J. and Choi, Y. H. 2013. Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1. PLoS One 8, e63425. crossref(new window)

Han, M. H., Kim, G. Y., Yoo, Y. H. and Choi, Y. H. 2013. Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. Toxicol. Lett. 220, 157-166. crossref(new window)

Hu, L., Hofmann, J., Lu, Y., Mills, G. B. and Jaffe, R. B. 2002. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res. 62, 1087-1092.

Jeong, S. Y. and Seol, D. W. 2008. The role of mitochondria in apoptosis. BMB Rep. 41, 1122.

Jin, Z. and El-Deiry, W. S. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4, 139-163.

Jourdain, A. and Martinou, J. C. 2009. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int. J. Biochem. Cell Biol. 41, 1884-1889. crossref(new window)

Kadenbach, B., Arnold, S., Lee, I. and Hüttemann, M. 2004. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta. 1655, 400-408. crossref(new window)

Kim, S., Lee, T. J., Leem, J., Choi, K. S., Park, J. W. and Kwon, T. K. 2008. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J. Cell. Biochem. 104, 895-907. crossref(new window)

Laster, L. L. and Lobene, R. R. 1990. New perspectives on Sanguinaria clinicals: individual toothpaste and oral rinse testing. J. Can. Dent. Assoc. 56, 19-30.

Lee, J. S., Jung, W. K., Jeong, M. H., Yoon, T. R. and Kim, H. K. 2012. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int. J. Toxicol. 31, 70-77. crossref(new window)

Mackraj, I., Govender, T. and Gathiram, P. 2008. Sanguinarine. Cardiovasc. Ther. 26, 75-83.

Park, H., Bergeron, E., Senta, H., Guillemette, K., Beauvais, S., Blouin, R., Sirois, J. and Faucheux, N. 2010. Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochem. Biophys. Res. Commun. 399, 446-451. crossref(new window)

Park, S. Y., Jin, M. L., Kim, Y. H., Lee, S. J. and Park, G. 2014. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression. Oncol. Rep. 31, 497-504.

Pica, F., Balestrieri, E., Serafino, A., Sorrentino, R., Gaziano, R., Moroni, G., Moroni, N., Palmieri, G., Mattei, M., Garaci, E. and Sinibaldi-Vallebona, P. 2012. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Anticancer Drugs 23, 32-42. crossref(new window)

Slunská, Z., Gelnarová, E., Hammerová, J., Táborská, E. and Slaninová, I. 2010. Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicol. In Vitro 24, 697-706. crossref(new window)

Sun, M., Liu, C., Nadiminty, N., Lou, W., Zhu, Y., Yang, J., Evans, C. P., Zhou, Q. and Gao, A. C. 2012. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 72, 82-89. crossref(new window)

Toker, A. and Yoeli-Lerner, M. 2006. Akt signaling and cancer: surviving but not moving on. Cancer Res. 66, 3963-3966. crossref(new window)

Vlachojannis, C., Magora, F. and Chrubasik, S. 2012. Rise and fall of oral health products with Canadian bloodroot extract. Phytother. Res. 26, 1423-1426.

Vogt, A., Tamewitz, A., Skoko, J., Sikorski, R. P., Giuliano, K. A. and Lazo, J. S. 2005. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J. Biol. Chem. 280, 19078-19086. crossref(new window)

Weerasinghe, P., Hallock, S., Tang, S. C., Trump, B. and Liepins, A. 2006. Sanguinarine overcomes P-glycoprotein-mediatedmultidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Exp. Toxicol. Pathol. 58, 21-30. crossref(new window)

Xu, J. Y., Meng, Q. H., Chong, Y., Jiao, Y., Zhao, L., Rosen, E. M. and Fan, S. 2012. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Oncol. Rep. 28, 2264-2270.

Xu, J. Y., Meng, Q. H., Chong, Y., Jiao, Y., Zhao, L., Rosen, E. M. and Fan, S. 2013. Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Mol. Clin. Oncol. 1, 331-336.

Yang, Y., Zhu, X., Chen, Y., Wang, X. and Chen, R. 2007. p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicine-induced cortical neurons apoptosis. Eur. J. Pharmacol. 576, 26-33. crossref(new window)